Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China

  1. Guqin Zhang
  2. Chang Hu
  3. Linjie Luo
  4. Fang Fang
  5. Yongfeng Chen
  6. Jianguo Li
  7. Zhiyong Peng
  8. Huaqin Pan

Reviewed by

Read the full article

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. ScreenIT

    SciScore for 10.1101/2020.03.02.20030452: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: Written informed consent was waived by the Ethics Commission for emerging infectious disease.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.
    Cell Line AuthenticationContamination: Respiratory specimens, including pharyngeal swabs, bronchoalveolar lavage fluid, sputum or bronchial aspirates were tested for other respiratory viruses including influenza A virus (H1N1, H7N9), influenza B virus, respiratory syncytial virus, parainfluenza virus, adenovirus, and other atypical pathogens such as mycoplasma, chlamydia and legionella pneumophila, which were also examined with real-time RT-PCR.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    All the statistical analyses were performed using the IBM SPSS version 24.0 (IBM Corp., Armonk, NY, USA).
    SPSS
    suggested: (SPSS, RRID:SCR_002865)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    35 The limitation of this study is that among the 221 cases, most of the patients were still hospitalized at the time of data collected. It is incomplete to assess risk factors for outcomes. Continued observation and dynamic clinical dataset are required.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  2. Version published to 10.1016/j.jcv.2020.104364
  3. Version published to 10.1101/2020.03.02.20030452v1 on medRxiv